IP Library Granted Patent US 9,693,908
Granted Patent B2
US 9,693,908 · App. 14/530,107 · Granted Jul 4, 2017

Wound treatment device employing negative pressure

Inventors: Elof Eriksson (Wellesley Hills, MA); Michael Broomhead (Scituate, MA)
Assignee: APPLIED TISSUE TECHNOLOGIES LLC
A61F13/00068A61F13/0216A61M1/0003A61M1/0011A61M1/0072A61M1/0088A61M1/0025A61M1/0084
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,693,908
App. No.
14/530,107
Granted
Jul 4, 2017
Kind
B2
Abstract

Devices and methods for wound treatment are disclosed. A chamber may define a treatment space having an interior engineered surface including a plurality of structures configured to provide pathways for the distribution of negative pressure and to exert mechanical stress on a wound. In some specific embodiments, the devices and methods may treat wounds on the head, neck, and face. One or more tubes may be in fluid communication with the treatment space to facilitate the application of negative pressure, the introduction of therapeutic agents, and the removal of wound material.

Claims (24)

1. A method of treating a patient having a facial wound, comprising:

debriding the facial wound;

fitting a wound treatment device over a head of the patient, the wound treatment device comprising:

a chamber configured to enclose a head and neck region of the patient, the chamber being made of an impermeable material that is sufficiently thin to conform to the head and neck of the patient, the chamber having a sealing portion at a base and an interior surface defining an isolated treatment space;

a plurality of embossed structures on the interior surface of the chamber, the structures being configured to directly contact the facial wound and to create pathways for distributing negative pressure between the interior surface of the chamber and the facial wound; and

at least one tube connected to the chamber and in fluid communication with the isolated treatment space so as to enable at least one of applying negative pressure to the isolated treatment space and applying a therapeutic agent to the facial wound;

applying at least one therapeutic agent to the facial wound via the device; and

applying negative pressure wound therapy to the isolated treatment space of the device for a sufficient duration to effect healing of the facial wound.

2. The method of claim 1 , further comprising one or more of: surgically or non-surgically closing a mouth and a nose of the patient; applying a protective shield over an eye of the patient; and applying a tracheostomy tube and a gastrostomy tube to the patient.

3. The method of claim 1 , wherein the plurality of embossed structures have a height of about 0.1 mm to about 5 mm.

4. The method of claim 3 , wherein the plurality of embossed structures are positioned at a distance of about 0.2 mm to about 10 mm apart from one another.

5. The method of claim 1 , wherein the plurality of embossed structures is positioned in a uniform pattern on the interior surface of the chamber.

6. The method of claim 5 , wherein each embossed structure has a shape selected from the group consisting of: a cone, a pyramid, a pentagon, a hexagon, a half sphere, a dome, a rod, an elongated ridge with round sides, and an elongated ridge with square sides.

7. The method of claim 1 , wherein the plurality of embossed structures intrudes into the isolated treatment space in a direction generally perpendicular to the interior surface of the chamber.

8. The method of claim 1 , wherein the device is configured to treat the facial wound for a prolonged duration of a healing process.

9. The method of claim 1 , wherein the chamber is formed from a single sheet of material.

10. The method of claim 1 , wherein the at least one tube is further configured to remove wound fluid from the isolated treatment space.

11. The method of claim 1 , wherein the plurality of embossed structures structure are semi-rigid.

12. The method of claim 1 , wherein the sealing portion includes a first surface having an adhesive.

13. The method of claim 1 , wherein the device further comprises at least one of: a fluid trap, an exhaust port, and a suction device.

14. The method of claim 1 , wherein the device further comprises a manual pump in fluid communication with the isolated treatment space to apply the negative pressure wound therapy.

15. The method of claim 1 , wherein the at least one therapeutic agent comprises an agent selected from the group consisting of: antimicrobials, antibiotics, antifungals, and analgesics.

16. The method of claim 1 , wherein the chamber does not comprise a porous insert.

17. The method of claim 1 , wherein the plurality of embossed structures covers at least 95 percent of the interior surface of the chamber.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2026
From: APPLIED TISSUE TECHNOLOGIES LLC
To: NEW HORIZON INNOVATIONS LLC
Reel/Frame 075163/0519 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2014
From: ERIKSSON, ELOF; BROOMHEAD, MICHAEL
To: APPLIED TISSUE TECHNOLOGIES LLC
Reel/Frame 034428/0443 →
Continuity (4)
Continuation In Part 14092004 · Nov 27, 2013
Continuation 12601394
Provisional Application 60931599 · May 24, 2007
Related Publication 20150119857A1 · Apr 30, 2015